Login
$PCRX
$36.49 +$0.02 (0.07%) Live

$PCRX 8-K/A SEC Filings

Filed On Filing
07 Feb 2022 8-K/A: Financial Statements and Exhibits

On November 19, 2021, Pacira BioSciences, Inc. (“Pacira” or the “Company”) completed the acquisition (the “Acquisition”) of Flexion Therapeutics, Inc. (“Flexion”), pursuant to an Agreement and Plan of Merger, dated October 11, 2021, by a...

06 Aug 2020 8-K/A: Results of Operations and Financial Condition

-- EXPAREL average daily sales return to year-over-year growth in month of June 2020 --

25 Jun 2019 8-K/A: Financial Statements and Exhibits

We have audited the accompanying consolidated financial statements of MyoScience, Inc., and its subsidiaries (the Company), which comprise the consolidated balance sheets as of December 31, 2018 and 2017, and the related consolidated sta...

07 Mar 2014 8-K/A: Departure/Election of Directors or Officers; Compensation

On March 4, 2014, the Board of Directors (the “Board”) of Pacira Pharmaceuticals, Inc. (the “Company”) appointed Dr. Yvonne Greenstreet to serve as a Class III director.

22 Jan 2014 8-K/A: Submission of Matters to a Vote of Security Holders

As previously reported, at the Company’s 2013 annual meeting of stockholders the option regarding the frequency (every year, every two years or every three years) of the advisory vote to approve the compensation of the Company’s named ex...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support